Keefe Bruyette downgraded Lazard from Outperform to Mkt Perform and set a new price target of $57.00 from $65.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/7/2025 | $56.00 → $33.00 | Equal-Weight → Underweight | Morgan Stanley |
| 1/3/2025 | Outperform → Peer Perform | Wolfe Research | |
| 12/20/2024 | $65.00 → $57.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/9/2024 | $60.00 → $63.00 | Overweight → Equal-Weight | Morgan Stanley |
| 9/12/2024 | $51.00 | Equal Weight | Wells Fargo |
| 1/29/2024 | $51.00 | Outperform | Keefe Bruyette |
| 1/3/2024 | $42.00 | Peer Perform → Outperform | Wolfe Research |
| 9/19/2023 | $37.00 → $32.00 | Neutral → Sell | Goldman |
Morgan Stanley downgraded Lazard from Equal-Weight to Underweight and set a new price target of $33.00 from $56.00 previously
Wolfe Research downgraded Lazard from Outperform to Peer Perform
Keefe Bruyette downgraded Lazard from Outperform to Mkt Perform and set a new price target of $57.00 from $65.00 previously